-

Aldevron Adds Self-Amplifying RNA to its Product Portfolio

FARGO, N.D.--(BUSINESS WIRE)--Aldevron, a global leader in the custom development and manufacture of plasmid DNA, proteins and mRNA for the biotech industry, announced today the addition of three reporter Self-amplifying RNA (saRNA) products to its growing catalog: AldGFP saRNA™, AldSEAP saRNA™ and AldnLUC saRNA™.

Alphavirus-derived saRNA encodes nonstructural proteins that enable self-replication, thereby allowing lower doses for genetic medicines and vaccines, and saRNA is being used to support next-generation COVID vaccine development. For these uses, Aldevron’s novel saRNA reporters enable rapid technology evaluation and delivery optimization.

“The use of saRNA to fight disease is growing exponentially and we are committed to providing our clients the highest quality biologics to support their work,” says Nate Spangler, Director of Innovation and Strategy for Aldevron. “We stock these reporter saRNAs for immediate delivery, and we can custom manufacture saRNA encoding any gene of interest."

The AldGFP saRNA™, AldSEAP saRNA™ and AldnLUC saRNA™ constructs are offered royalty free for research use only and are available in packs of 200 µg, 1mg and custom sizes.

About Aldevron

Aldevron is a privately held company founded in 1998. It serves the biotechnology industry with custom production of nucleic acids and proteins. Thousands of clients use Aldevron-produced plasmids, RNA and gene editing enzymes for projects ranging from discovery research to clinical trials to commercial applications. These products are critical raw materials and key components for vaccine development, gene and cell therapy, immunotherapy, agricultural biotech, veterinary medicines, molecular diagnostics and more. Aldevron is known for inventing the GMP-Source® quality system, and for specializing in GMP manufacturing, operating the world’s largest facility at its Company headquarters in Fargo, North Dakota. The company’s protein development and manufacturing operations are located in Madison, Wisconsin. To learn more, visit www.aldevron.com.

Contacts

Ellen Shafer
Senior Director of Marketing and Communications
ellen.shafer@aldevron.com
701.297.9256

ALDEVRON

Details
Headquarters: Fargo, ND, USA
CEO: Kevin Ballinger
Employees: 500+
Organization: PRI

Release Versions

Contacts

Ellen Shafer
Senior Director of Marketing and Communications
ellen.shafer@aldevron.com
701.297.9256

Social Media Profiles
More News From ALDEVRON

Aldevron Expands Commercial Leadership Team With Addition of Two Industry Veterans

FARGO, N.D.--(BUSINESS WIRE)--Aldevron, the world’s leading biomanufacturer of plasmid DNA, mRNA and proteins, is expanding its commercial leadership with the addition of Beth Thompson-Webb as Chief Commercial Officer and Todd Howren as Vice President of Sales. Thompson-Webb will be responsible for leading Aldevron’s worldwide sales and marketing strategy where she will utilize her 30 years of industry experience to drive strategic growth and service initiatives. Thompson-Webb will report to Ke...

Aldevron Now Offering AAV Rep/Cap Plasmids for Viral Vector Production

FARGO, N.D.--(BUSINESS WIRE)--Aldevron announced today the immediate availability of rep/cap plasmids pALD-AAV2, AAV5 and AAV6 to support AAV viral vector manufacturing. All three rep/cap plasmids are immediately available at Research Grade. Additionally, pALD-AAV6 is immediately available at the GMP-Source® quality level, while pALD-AAV2 and pALD-AAV5 will be made available based on market demand. The plasmids are royalty free for all applications in support of pre-clinical activities through...

Aldevron Names Shawn McCormick Chief Financial Officer

FARGO, N.D.--(BUSINESS WIRE)--Aldevron, a global leader in the manufacture of plasmid DNA, mRNA and proteins, today announced Shawn McCormick as its Chief Financial Officer. He will begin this new role immediately and will be a member of Aldevron’s executive team reporting to CEO Kevin Ballinger. McCormick is replacing Marc Wolff, Aldevron’s CFO since 2018, who will be departing the company at year end. “I am very excited to announce the addition of Shawn to Aldevron,” said Kevin Ballinger, CEO...
Back to Newsroom